ATE322250T1 - Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen - Google Patents

Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen

Info

Publication number
ATE322250T1
ATE322250T1 AT00115408T AT00115408T ATE322250T1 AT E322250 T1 ATE322250 T1 AT E322250T1 AT 00115408 T AT00115408 T AT 00115408T AT 00115408 T AT00115408 T AT 00115408T AT E322250 T1 ATE322250 T1 AT E322250T1
Authority
AT
Austria
Prior art keywords
fat
self
drug delivery
active ingredients
soluble active
Prior art date
Application number
AT00115408T
Other languages
English (en)
Inventor
Sue San David Ho
Kah Hay Assoc Prof Dr Yuen
Siew Ping Yap
Original Assignee
Hovid Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovid Sdn Bhd filed Critical Hovid Sdn Bhd
Application granted granted Critical
Publication of ATE322250T1 publication Critical patent/ATE322250T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT00115408T 2000-07-07 2000-07-17 Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen ATE322250T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/612,434 US6596306B1 (en) 2000-07-07 2000-07-07 Drug delivery system:formulation for fat-soluble drugs

Publications (1)

Publication Number Publication Date
ATE322250T1 true ATE322250T1 (de) 2006-04-15

Family

ID=24453141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00115408T ATE322250T1 (de) 2000-07-07 2000-07-17 Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen

Country Status (9)

Country Link
US (1) US6596306B1 (de)
EP (1) EP1170003B1 (de)
AT (1) ATE322250T1 (de)
CY (1) CY1105026T1 (de)
DE (1) DE60027142T2 (de)
DK (1) DK1170003T3 (de)
ES (1) ES2255924T3 (de)
PT (1) PT1170003E (de)
TW (1) TWI222880B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100361656C (zh) 2004-08-27 2008-01-16 石药集团中奇制药技术（石家庄）有限公司 丁苯酞自乳化释药体系及其制备方法和应用
MY139644A (en) * 2005-02-17 2009-10-30 Palm Nutraceuticals Sdn Bhd Improving the quality of crude oils and fats and recovery of minor components
NZ582332A (en) * 2007-05-25 2012-02-24 Univ British Columbia Formulations for the oral administration of amphotericin b and related methods
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
WO2011050457A1 (en) 2009-10-26 2011-05-05 The University Of British Columbia Stabilized formulation for oral administration of therapeutic agents and related methods
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
EP2768486B1 (de) * 2011-10-21 2018-10-03 First Tech International Limited Tocotrienolzusammensetzungen
DK2819998T3 (da) 2012-03-01 2022-04-19 Array Biopharma Inc Krystallinske former af 1-(3-tert-butyl-1-P-tolyl-1H-pyrazol-5-yl)-3-(5-fluor-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)ureahydrochlorid
KR20150030667A (ko) * 2012-05-18 2015-03-20 더 오하이오 스테이트 유니버시티 간 기능을 개선시키는 방법
CN104507468A (zh) * 2012-06-08 2015-04-08 俄亥俄州立大学 用于改善软膜侧支循环和治疗血液凝固障碍的方法与组合物
WO2013185024A1 (en) * 2012-06-08 2013-12-12 The Ohio State University Treating burn and scar injury using tocotrienol
KR102397569B1 (ko) * 2014-06-19 2022-05-12 솔루랄 파마 에이피에스 친유성 화합물의 고형 경구 투여 형태
MY182652A (en) * 2014-11-25 2021-01-27 Kl Kepong Oleomas Sdn Bhd Formulation for effective tocotrienol delivery
WO2016109853A2 (en) 2015-01-02 2016-07-07 Melaleuca, Inc. Dietary supplement compositions
TWI788111B (zh) 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
TWI829098B (zh) 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物
US20240058300A1 (en) * 2021-01-06 2024-02-22 The Trustees Of Indiana University Tocotrienol compositions and methods to treat non-alcoholic steatohepatitis
MY203355A (en) 2021-12-27 2024-06-25 Sd Guthrie Intellectual Property Sdn Bhd Self-emulsifying composition
WO2025153898A1 (en) * 2024-01-19 2025-07-24 Gene Company Pty Ltd Retinoid compositions and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141051A3 (de) * 1983-08-16 1986-10-01 Roshdy Dr. Ismail Weichgelatinekapseln enthaltend Vitamin A und E
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
DE69535127T2 (de) * 1994-03-18 2007-02-15 Supernus Pharmaceuticals, Inc. Emulgierte arzneistoffabgabesysteme
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5479540A (en) * 1994-06-30 1995-12-26 The Whitaker Corporation Passively aligned bi-directional optoelectronic transceiver module assembly
IT1275955B1 (it) * 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US5883103A (en) * 1995-06-07 1999-03-16 Shire Laboratories Inc. Oral acyclovir delivery
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
GB9817650D0 (en) * 1998-08-14 1998-10-07 Danbiosyst Uk Oral formulation
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6309633B1 (en) * 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same

Also Published As

Publication number Publication date
DK1170003T3 (da) 2006-08-07
DE60027142T2 (de) 2006-12-14
EP1170003B1 (de) 2006-04-05
CY1105026T1 (el) 2009-11-04
US6596306B1 (en) 2003-07-22
TWI222880B (en) 2004-11-01
PT1170003E (pt) 2006-06-30
EP1170003A1 (de) 2002-01-09
DE60027142D1 (de) 2006-05-18
ES2255924T3 (es) 2006-07-16

Similar Documents

Publication Publication Date Title
DE60027142D1 (de) Selbstemulgierendes System zur Arzneistoffabgabe von fettlöslichen Wirkstoffen
DE60131862D1 (de) Herstellung von vitaminemulsionen und konzentrate davon
Toorisaka et al. Hypoglycemic effect of surfactant-coated insulin solubilized in a novel solid-in-oil-in-water (S/O/W) emulsion
DE50011907D1 (de) Mikrokapseln
ATE276741T1 (de) Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung
ATE415942T1 (de) Prostaglandine enthaltende ophthalmische emulsionen
NO20002991L (no) Farmasøytiske sammensetninger som inneholder en <omega>-3- fettsyreolje
ATE415943T1 (de) Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff
WO2007106284A3 (en) Silicone based emulsions for topical drug delivery
EE200200500A (et) Uus iseemulgeeruv ravimi manustamise süsteem
EA200301019A1 (ru) Доставляемая перорально фармацевтическая композиция, включающая препарат с низкой растворимостью в воде (ингибитор cox-2), растворитель, жирную кислоту и органический амин
MY137749A (en) New self emulsifying drug delivery system
IL151311A0 (en) Pharmaceutical compositions containing propofol
SE0102993D0 (sv) New self emulsifying drug delivery system
MY120392A (en) A novel drug delivery system : formulation for fat-soluble drugs
PL440642A1 (pl) Kompozycja tworząca w wodzie stabilną emulsję monodyspersyjną zawierająca substancję aktywną rozpuszczalną w tłuszczach
TH100976B (th) ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่
TH102356B (th) ระบบนำส่งยาแบบอีมัลซิฟายตัวเองชนิดใหม่
WO2005072679A3 (es) Formulación adyuvante conteniendo una emulsión oleosa con aceite de jojoba
WO2012054393A2 (en) Bioavailability enhancement delivery system

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties